A History of Left Atrial Appendage Occlusion

David Holmes, Robert S. Schwartz, George G. Latus, Robert A. Van Tassel

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

A new era in antiembolic therapy has been initiated by the growing numbers of device-based therapies. Early concerns surrounding eliminating this enigmatic structure have not proven true. Other benefits are being further evaluated. Many other questions remain, such as whether there is a device-specific outcome effect or whether it is a class effect. Other questions include other devices, what head-to-head studies will show, and the impact of residual leak. Left atrial appendage using the Watchman ablation strategy can reduce cardioembolic stroke, with comparable or fewer adverse effects by device technology than obtained by long-term anticoagulation with its attendant bleeding risks.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalInterventional Cardiology Clinics
Volume7
Issue number2
DOIs
StatePublished - Apr 1 2018

Fingerprint

Atrial Appendage
Equipment and Supplies
Stroke
Hemorrhage
Technology
Therapeutics

Keywords

  • Antiembolic therapy
  • Atrial fibrillation
  • Left atrial appendage
  • Watchman ablation strategy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

A History of Left Atrial Appendage Occlusion. / Holmes, David; Schwartz, Robert S.; Latus, George G.; Van Tassel, Robert A.

In: Interventional Cardiology Clinics, Vol. 7, No. 2, 01.04.2018, p. 143-150.

Research output: Contribution to journalReview article

Holmes, David ; Schwartz, Robert S. ; Latus, George G. ; Van Tassel, Robert A. / A History of Left Atrial Appendage Occlusion. In: Interventional Cardiology Clinics. 2018 ; Vol. 7, No. 2. pp. 143-150.
@article{14b831f384454cf9a84ee105788f6da3,
title = "A History of Left Atrial Appendage Occlusion",
abstract = "A new era in antiembolic therapy has been initiated by the growing numbers of device-based therapies. Early concerns surrounding eliminating this enigmatic structure have not proven true. Other benefits are being further evaluated. Many other questions remain, such as whether there is a device-specific outcome effect or whether it is a class effect. Other questions include other devices, what head-to-head studies will show, and the impact of residual leak. Left atrial appendage using the Watchman ablation strategy can reduce cardioembolic stroke, with comparable or fewer adverse effects by device technology than obtained by long-term anticoagulation with its attendant bleeding risks.",
keywords = "Antiembolic therapy, Atrial fibrillation, Left atrial appendage, Watchman ablation strategy",
author = "David Holmes and Schwartz, {Robert S.} and Latus, {George G.} and {Van Tassel}, {Robert A.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.iccl.2017.12.005",
language = "English (US)",
volume = "7",
pages = "143--150",
journal = "Interventional Cardiology Clinics",
issn = "2211-7458",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - A History of Left Atrial Appendage Occlusion

AU - Holmes, David

AU - Schwartz, Robert S.

AU - Latus, George G.

AU - Van Tassel, Robert A.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - A new era in antiembolic therapy has been initiated by the growing numbers of device-based therapies. Early concerns surrounding eliminating this enigmatic structure have not proven true. Other benefits are being further evaluated. Many other questions remain, such as whether there is a device-specific outcome effect or whether it is a class effect. Other questions include other devices, what head-to-head studies will show, and the impact of residual leak. Left atrial appendage using the Watchman ablation strategy can reduce cardioembolic stroke, with comparable or fewer adverse effects by device technology than obtained by long-term anticoagulation with its attendant bleeding risks.

AB - A new era in antiembolic therapy has been initiated by the growing numbers of device-based therapies. Early concerns surrounding eliminating this enigmatic structure have not proven true. Other benefits are being further evaluated. Many other questions remain, such as whether there is a device-specific outcome effect or whether it is a class effect. Other questions include other devices, what head-to-head studies will show, and the impact of residual leak. Left atrial appendage using the Watchman ablation strategy can reduce cardioembolic stroke, with comparable or fewer adverse effects by device technology than obtained by long-term anticoagulation with its attendant bleeding risks.

KW - Antiembolic therapy

KW - Atrial fibrillation

KW - Left atrial appendage

KW - Watchman ablation strategy

UR - http://www.scopus.com/inward/record.url?scp=85043389128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043389128&partnerID=8YFLogxK

U2 - 10.1016/j.iccl.2017.12.005

DO - 10.1016/j.iccl.2017.12.005

M3 - Review article

C2 - 29526283

AN - SCOPUS:85043389128

VL - 7

SP - 143

EP - 150

JO - Interventional Cardiology Clinics

JF - Interventional Cardiology Clinics

SN - 2211-7458

IS - 2

ER -